Psychopharmacology Research Unit- Nathan KIine Institute for Psychiatric Research — New York, New York

Psychopharmacology Research Unit- Nathan KIine Institute for Psychiatric Research is a clinical research site located in New York, New York, United States 10035.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Psychopharmacology Research Unit- Nathan KIine Institute for Psychiatric Research has participated in 1 clinical trials.

Therapeutic areas: Schizophrenia.

Sponsors: New York State Psychiatric Institute.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Psychopharmacology Research Unit- Nathan KIine Institute for Psychiatric Research?

Psychopharmacology Research Unit- Nathan KIine Institute for Psychiatric Research has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Psychopharmacology Research Unit- Nathan KIine Institute for Psychiatric Research conducted?

Psychopharmacology Research Unit- Nathan KIine Institute for Psychiatric Research has 1 clinical trials on record. Their work covers Schizophrenia.

Is Psychopharmacology Research Unit- Nathan KIine Institute for Psychiatric Research accredited by Crixeo Health?

Psychopharmacology Research Unit- Nathan KIine Institute for Psychiatric Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Psychopharmacology Research Unit- Nathan KIine Institute for Psychiatric Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.